Skip navigation

Calls to Action

King's College London

Pharmaceutical Companies, Advocacy Organizations, and Universities Join Forces to Discover New Drugs and Assess Novel Treatment Approaches for Autism

An international consortium of scientists, led by Roche, King’s College London, and Autism Speaks, is collaborating on one of the larg

March 13, 2012

(March 19)

An international consortium of scientists, led by Roche, King’s College London, and Autism Speaks,  is collaborating on one of the largest ever academic-industry research projects to find new methods for the development of drugs for autism spectrum disorder (ASD).  

European Autism Interventions – A Multicentre Study for Developing New Medications(EU-AIMS) is the largest single grant for autism research in the world and the largest for the study of any mental health disorder in Europe.